Vendor, Rockville, MD, part of Aurinia Pharmaceuticals Inc.
Aurinia Pharma US Inc.
UEI Y394MPDW6GH4, CAGE 8RTT6
3 awards and $0 obligated between January 30, 2024 and August 25, 2026, 100% under full and open competition, against 333.7 offers on average where reported.
How it wins
Awards by competition, set-aside and type.
| Full and Open Competition | 3 |
Awards
Every award in the window, by dollars obligated.
| Contract | Awarding office | Described as | Obligated |
|---|---|---|---|
| 36E79721A0019July 15, 2024, Full and Open Competition, 1 offers | Nac PharmaceuticalsDepartment of Veterans Affairs | Exercise Option Year 3NAICS 325412, PSC 6505 | $0 |
| 36E79726A0022August 25, 2026, Full and Open Competition, 1 offers | Nac PharmaceuticalsDepartment of Veterans Affairs | BPA for LupkynisNAICS 325412, PSC 6505 | $0 |
| 36F79721D0217January 30, 2024, Full and Open Competition, 999 offers | Nac Federal Supply ScheduleDepartment of Veterans Affairs | Admin Annual Rebate RemovalNAICS 325412, PSC 6505 | $0 |
- Product and service codes
- 6505 Drugs and Biologicals
- Transactions
- 13 across 3 awards